It has been shown to be associated with stroke in the course of SLE and with the presence of antiphospholipid antibodies (APLA): anti-cardiolipin (aCL), lupus anticoagulants (LA), and anti-beta 2 glycoprotein 1 (35–38). The gene discussed is ACLY; the disease is systemic lupus erythematosus.